Multidisciplinary Respiratory Medicine Q3
Unclaimed
Multidisciplinary Respiratory Medicine is a journal indexed in SJR in Pulmonary and Respiratory Medicine with an H index of 46. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1507 €. The scope of the journal is focused on pulmonary medicine. It has an SJR impact factor of 0,415 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,415.
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
1507 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,415
SJR Impact factor46
H Index32
Total Docs (Last Year)89
Total Docs (3 years)1214
Total Refs117
Total Cites (3 years)85
Citable Docs (3 years)1.32
Cites/Doc (2 years)37.94
Ref/DocOther journals with similar parameters
Canadian Respiratory Journal Q3
Advances in Respiratory Medicine Q3
Experimental Lung Research Q3
Archivos de Bronconeumologia Q3
Respiratory Medicine and Research Q3
Compare this journals
Aims and Scope
Best articles by citations
Novel aspects in diagnostic approach to respiratory patients: is it the time for a new semiotics?
View moreClinical course and management of idiopathic pulmonary fibrosis
View moreRole of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections
View moreThe effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural models
View moreVenous thromboembolism and lung cancer: a review
View moreJAK2 V617F mutation negative erythrocytosis (or how to more simply perform diagnosis and treat a patient with increased hematocrit)
View moreState of the art in tracheal surgery: a brief literature review
View moreInterobserver variability of ventilatory anaerobic threshold in asymptomatic volunteers
View moreTime for physicians to be aware of molecular genetic testing
View moreImmunostimulants in respiratory diseases: focus on Pidotimod
View moreInfluenza and influenza-like syndromes: the subjects' beliefs, the attitude to prevention and treatment, and the impact in Italian general population
View moreStudy of the role of exhaled nitric oxide (NO) in predicting controlled or uncontrolled asthma in asthmatic children
View moreBronchiectasis in PCD looks different to CF on CT scan
View moreEndoscopic posterior cordotomy for treatment of dyspnea due to vocal fold immobility
View moreMotivation and response rates in bronchoscopy studies
View moreOpinions of healthcare providers on the design of a smartphone application for asthma treatment in the Kingdom of Saudi Arabia
View moreWhen to perform a bronchial challenge with mannitol?
View moreExamining the social status, risk factors and lifestyle changes of tuberculosis patients in Sri Lanka during the treatment period: a cross-sectional study
View moreThe physiological basis and clinical significance of lung volume measurements
View moreWhen and how ruling out cystic fibrosis in adult patients with bronchiectasis
View moreFocus on the cetirizine use in clinical practice: a reappraisal 30 years later
View moreAmbroxol for the treatment of children with acute and chronic respiratory diseases: an overview of efficacy and safety
View moreBreathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure
View moreTreating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review
View more
Comments